NDC 53225-2001-01 - Prolaxa
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 53225-2001
- Requested NDC
- 53225-2001-01
- Package NDCs from labels
- 53225-2001-1, 53225-2001-01
- Manufacturer
- Advanced Rx of Tennessee, LLC
- Effective date
- 2025-08-05
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Prolaxa - Advanced Rx of Tennessee, LLC | Advanced Rx of Tennessee, LLC | 2025-08-05 | HUMAN OTC DRUG LABEL |
| Prolaxa - Terrain Pharmaceuticals | Terrain Pharmaceuticals | 2025-06-12 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 53225-2001-1 | Prolaxa | 100 in 1 BOTTLE, PLASTIC | CAPSULE, LIQUID FILLED | 100 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 53225-2001 | PROLAXA (DOCUSATE SODIUM 250MG) CAPSULE, LIQUID FILLED [TERRAIN PHARMACEUTICALS] | 1 | Current NDC, 1 package rows | 20250416_32610e42-f352-09fd-e063-6394a90abff6.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 53225-2001-1 | EA - Each | 53225-2001 | aa1310eb-6faa-4bfc-a75f-85befacab3b4 | 1 | 2025-06-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Optase | GLYCERIN | Scope Health Inc | d81c1a4f-87b0-ee8c-e053-2995a90af9e5 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | f452a2c4-c869-7bf5-e053-2995a90ac1a0 | 2026-01-30 | Warnings | PDC6A3C0OX |
| Regener-Eyes Ophthalmic Solution LITE XL | GLYCERIN OPHTHALMIC SOLUTION | M & M PRODUCTS, L.L.C. | 47ab9609-4291-30b2-e063-6394a90a421e | 2026-01-29 | Warnings | PDC6A3C0OX |
| Regener-Eyes Ophthalmic Solution PROFESSIONAL STRENGTH XL | GLYCERIN OPHTHALMIC SOLUTION | M & M PRODUCTS, L.L.C. | 48d6dc98-66e8-b499-e063-6394a90ae935 | 2026-01-29 | Warnings | PDC6A3C0OX |
| SENNA-S | DOCUSATE SODIUM AND SENNOSIDES | Strategic Sourcing Services, LLC | 905bd658-a0af-4f20-be3d-00c54868a26c | 2026-01-29 | Warnings | M007 F05Q2T2JA0 |
| Senna Laxative | SENNOSIDES | Strategic Sourcing Services LLC | 9248a907-a8bd-47d5-98a2-48534d6023d4 | 2026-01-29 | Warnings | M007 |
| Leader Castor Oil | CASTOR OIL | Cardinal Health, 110 dba Leader | 49e3a40a-b717-43f6-abed-473d7ed03c2e | 2026-01-29 | Warnings, Adverse reactions | M007 |
| Mineral Oil | MINERAL OIL | CARDINAL HEALTH 110, LLC. DBA LEADER | 803f444f-d136-4f06-9842-24a71a3d7d6b | 2026-01-29 | Warnings, Adverse reactions | M007 |
| Optase | GLYCERIN | Scope Health Inc | 86c14327-ffc7-806e-e053-2991aa0aaf92 | 2026-01-29 | Warnings | PDC6A3C0OX |
| Equate Ready-to-Use Enema Laxative | SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM AND SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM | WalMart | 04c7440e-5b25-4b63-9604-321298d51021 | 2026-01-29 | Warnings | M007 |
| Stool Softener Laxative | DOCUSATE SODIUM | Meijer Distribution Inc. | 81edf0d8-b6f3-4b3a-85db-0108160756b1 | 2026-01-28 | Warnings | M007 F05Q2T2JA0 |
| Quality Choice Laxative | SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM AND SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM | Chain Drug Marketing Association | 1cac3b6b-155b-47bb-bb79-17c55d345736 | 2026-01-28 | Warnings | M007 |
| Docusate Sodium and Sennosides | DOCUSATE SODIUM AND SENNOSIDES | SOFTGEL HEALTHCARE PRIVATE LIMITED | 1ad73079-ebb3-dae7-e063-6294a90a0558 | 2026-01-28 | Warnings | M007 F05Q2T2JA0 |
| Regener-Eyes Ophthalmic Solution PROFESSIONAL | GLYCERIN OPHTHALMIC SOLUTION | M & M PRODUCTS, LLC | 49771efa-6682-51d0-e063-6294a90a18a5 | 2026-01-28 | Warnings | PDC6A3C0OX |
| Regener-Eyes Ophthalmic Solution LITE | GLYCERIN OPHTHALMIC SOLUTION | M & M PRODUCTS, LLC | 497763ee-dc70-bb48-e063-6294a90afb3d | 2026-01-28 | Warnings | PDC6A3C0OX |
| DOCUSATE SODIUM 100MG | DOCUSATE SODIUM 100MG | Farmacias De Similares TX LLC | 44269b79-a5ad-f443-e063-6294a90a8473 | 2026-01-28 | Warnings | M007 F05Q2T2JA0 |
| Docusate Sodium and Sennosides | DOCUSATE SODIUM AND SENNOSIDES | SOFTGEL HEALTHCARE PRIVATE LIMITED | 19830f9a-27b1-910d-e063-6294a90adace | 2026-01-27 | Warnings | M007 F05Q2T2JA0 |
| Sennosides | SENNOSIDES | SOFTGEL HEALTHCARE PRIVATE LIMITED | 94936bd4-8bbf-6211-e053-2995a90a2138 | 2026-01-27 | M007 | |
| Sennosides | SENNOSIDES | Softgel Healthcare Pvt Ltd | 16582306-7321-6c7c-e063-6394a90a509e | 2026-01-27 | Warnings | M007 |
| Vegetable Laxative | SENNOSIDES | Wal-Mart Stores Inc | 97695092-1ded-4723-a015-fdadd7c28c81 | 2026-01-27 | Warnings | M007 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.